Vector Laboratories’ blog provides a wealth of information on immunohistochemistry (IHC), immunofluorescence (IF), and related life science research topics.
There are three Engevik sisters—Kristen, Amy, and Mindy—all of whom chose to pursue academic careers in the field of gastrointestinal research. Here we focus on Amy, the middle child, who just started her own research... Read more
Like many other companies around the world, Vector Laboratories has looked inward during the last 2 years and spent time reflecting on its future and place in the scientific community. Change brings opportunity, and we... Read more
BURLINGAME, Calif.March 16, 2022 Relocation driven by increased demand for Vector Laboratories’ growing areas of focus, glycomics and proteomics Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today opened its new facility in... Read more
The parasitic sea lamprey has long remained the fishermen’s nightmare for harming fish in the Atlantic Ocean. However, their unique immune system could pave the way to substantial improvements in human glycome analysis. We review... Read more
Interfering background signal, such as autofluorescence, which is fluorescence inherent or endogenous to tissue, cell, or due to certain fixatives, can hamper your ability to accurately distinguish real target antigen expression. In a recent webinar,... Read more
Choosing the appropriate immunohistochemistry detection reagent can be a daunting task. Here are some considerations to guide you on your path to staining success.
BURLINGAME, Calif.February 2, 2022 Key appointment will support the company’s commercial growth plans to deliver proteomics and protein innovations worldwide Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today announced the addition of... Read more
Abdelrahman “Abdel” Fouda officially launched his long-term academic career as an Assistant Professor at the University of Arkansas for Medical Sciences (Little Rock, Arkansas) in the middle of July 2021. Since then, Abdel has been... Read more
The use of several promising drugs as treatments for autoimmune and inflammatory diseases has long been limited due to their toxic side effects. Wang et al. demonstrate how these barriers could be overcome with a... Read more
Pancreatic cancer is one of the deadliest cancers, especially when diagnosed at a later stage because of the lack of accurate biomarkers. Linking these biomarkers to cellular modifications is a promising approach to improve tumor... Read more
